ResearchAndMarkets.com released a comprehensive report covering over 1,859 clinical-stage partnering deals in pharmaceuticals and biotechnology from 2020 to 2026. The report includes detailed financial terms such as upfront payments, milestones, and royalties, along with direct access to contract documents filed with the SEC. It offers valuable insights into deal structures, negotiation strategies, and key industry players, helping companies benchmark and optimize their clinical-stage partnerships. This resource is essential for professionals involved in biopharma dealmaking to understand market trends and improve negotiation outcomes.
Teleflex reported Q2 revenue of $570.3 million, driven by its Vascular and Surgical segments, with adjusted EPS up 1.7% to $1.76. The company is selling its Acute Care, Interventional Urology, and OEM businesses for about $2.03 billion in cash to red...
Sun Life Financial reported strong Q2 results with earnings of $1.46 per share and revenues of $10.10 billion, surpassing analyst expectations. Growth was driven by a 27% rise in group insurance sales, 16% increase in individual sales, and a 10% boos...
Perion Network reported Q2 earnings with an EPS of $0.09, surpassing analyst estimates despite a revenue decline to $98.24 million from $102.98 million last year. The company is strategically moving away from traditional open-web advertising toward h...
Varex Imaging reported Q3 earnings with an EPS of $0.31, surpassing analyst estimates of $0.21, driven by growth in industrial and cargo inspection sectors. Revenue slightly missed expectations at $210.5 million versus $215.5 million forecast, but sa...
LCI Industries improved its profitability with an 8% rise in adjusted operating profit and a 110 basis point increase in operating margin, despite a 4% decline in net sales and weaker demand in the outdoor recreation market. Sales to OEMs fell 10%, a...
